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Objectives. This study assessed the incremental prognostic 
implications of normal and equivocal exercise techuetium-99m 
(Tc-99m) sestamibi s ngle-photon emission computed tomography 
(SPECT) and sought to determine its incremental prognostic 
value, impact on patient management and cost implications. 
Background. The prognostic implications of Tc-99m sestamibi 
SPECT are not well defined, and risk stratification using this test 
has not been explored. 
Methods. We studied 1,702 patients referred for exercise Tc- 
99m sestamibi SPECT who were followed up for a mean (-+SD) of 
20 -+ 5 months. Patients with previous pereutaneous transluminal 
coronary angioplasty or coronary artery bypass surgery were 
excluded. The SPECT studies were assessed using semiquantita- 
tive visual analysis. Cardiac death and myocardial infarction were 
considered "hard" events, and coronary angioplasty and bypass 
surgery >60 days after testing were considered "soft" events. 
Results. Of the 1,702 patients tudied, 1,131 had normal or 
equivocal scan results. A total of 10 events occurred in this group 
(1 cardiac death and 1 myocardial infarction [0.2% hard events]; 
4 coronary angioplasty and 4 bypass urgery procedures [0.7% soft 
events]). The rates of hard events and referral to catheterization 
after SPECT were similarly low in patients with a low (<0.15), 
intermediate (0.15 to 0.85) and high (>0.85) post-exercise treadmill 
test (ETr) likelihood of coronary artery disease. With respect to scan 
type, patients with normal, probably normal or equivocal scan results 
had similarly low hard event rates. In the 571 patients with abnormal 
scan results, there were 43 hard events (7.5%) and 42 soft events 
(7.4%) (p < 0.001 vs. 1,131 patients with normal scan results for 
both). When the complete spectrum of scan responses was consid- 
ered, SPECT provided incremental prognostic value in all patient 
subgroups analyzed. However, the nuclear scan was cost.e~ective 
only in patients with interpretable exercise ECG responses and an 
intermediate to high post-ETf likelihood of coronary artery disease 
and in those with uninterpretable exercise ECG responses and an 
intermediate to high pre-ETr likelihood of coronary artery disease. 
Conclusions. Normal or equivocal exercise Tc-99m sestamibi 
study results are associated with a benign prognosis, even in patients 
with a high likelihood of coronary artery disease. Although incre- 
mental prognostic value is added by nuclear testing in all patient 
subgroups, a testing strategy incorporating uclear testing proved to 
be cost.effective only in the groups with an intermediate o high 
likelihood of coronary artery disease before scanning. 
(J Am Coll Cardiol 1995;26:639-47) 
In the 1970s, exercise myocardial perfusion scintigraphy be- 
came established as an effective clinical tool for detecting 
coronary artery disease, providing incremental information 
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over clinical and exercise data in patients with an intermediate 
likelihood of disease (1-4). In the 1980s, the technique was 
applied to assessment of patient prognosis (5-7), and it was 
demonstrated (8) that the greatest incremental prognostic 
information from nuclear scanning occurred in patients with a 
high likelihood of coronary artery disease. Most of the studies 
that assessed prognosis with exercise myocardial perfusion 
scintigraphy were performed with thallium-201. 
Recently anew radiopharmaceutical, technetium-99m (Tc- 
99m) sestamibi, has been widely used for the assessment of 
exercise myocardial perfusion (9). This agent has been dem- 
onstrated to have a sensitivity and specificity very similar to 
that of tfiallium-201 for detecting angiographically significant 
coronary artery disease (10-12). Although the benign progno- 
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sis associated with normal exercise thallium-201 study results 
has been well documented (6-8,13-15), relatively little data 
exist regarding the prognostic implications of normal exercise 
Tc-99m sestamibi study results (16,17). Several reports (18-20) 
have in fact suggested that the size and severiW of perfusion 
defects may be underestimated with exercise Tc-99m sestamibi 
studies compared with exercise thallium-20l studies. If this 
were true, the prognostic implications of an equivocal Tc-99m 
sestamibi scan might be the same as those of an abnormal 
thallium-201 scan with a small perfusion defect. Because the 
latter has been shown (6,7) to be associated with an event rate 
greater than that associated with normal scans, this possibility 
is of concern. 
To our knowledge, the incremental prognostic value of 
normal exercise Tc-99m sestamibi scan has not been examined. 
The goals of the current study were to evaluate the prognostic 
implications of normal and equivocal scans with this new agent 
and to determine incremental prognostic value, effect on 
patient management and cost implications of exercise Tc-99m 
sestamibi single-photon computed tomography (SPECT). 
Methods 
Study population. The initial population evaluated for the 
present study comprised a consecutive group of 2,149 patients 
in whom exercise dual-isotope SPECT was performed between 
January 1, 1991 and January l, 1993. Follow-up of each 
patient's clinical state was performed at >_ 1 year after testing. 
One hundred two patients could not be located for follow-up; 
three patients were found to have a technically inadequate 
study for interpretation; and four patients had incomplete 
data, resulting in a study population of 2,040 patients (95% of 
the initial population). The 338 patients with a history of 
previous percutaneous transluminal coronary angioplasty or 
coronary bypass surgery were eliminated from the study, 
leaving a final population of 1,702 patients. 
Exercise myocardial perfusion protocol. All patients un- 
derwent rest thallium-201/exercise Tc-99m sestamibi separate- 
acquisition dual-isotope myocardial perfusion SPECT, as pre- 
viously described (21,22). We developed this protocol as our 
clinical routine because of its high eMciency and the advan- 
tages of Tc-99m sestamibi for stress perfusion (9,23) and 
rest-redistribution thallium-201 for assessing viability in hiber- 
nating myocardium (24-26). Briefly, thallium-201 (2.5 to 
3.5 mCi) was injected intravenously at rest, with dose variation 
based on patient weight. Rest thallium-201 SPECT was begun 
10 rain after injection of the radioisotope. When defect 
reversibility was expected, but not evident, patients with 
thallium-201 defects underwent redistribution thallium-201 
imaging -24 h after the stress tudy. All patients performed a 
symptom-limited xercise treadmill test (ETI') using the stan- 
dard Bruce protocol with 12-lead electrocardiographic (ECG) 
recording each minute of exercise and continuous monitoring 
of leads aVF, V 1 and V s. Exercise nd points included physical 
exhaustion, severe angina, ventricular tachycardia, hemody- 
namically significant supraventricular rrhythmias or signifi- 
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Figure 1. Assignment ofmyocardial regions for single-photon emis- 
sion computed tomographic (SPECT) images. In general, scans with 
multiple segments with stress/rest scores of 1-0 or a single segment with 
a stress score of 2 were classified as equivocal. Those with two segments 
with a stress score of 2 were classified asprobab~' abnormal and those with 
more than two stress segments with a score of 2 or one or more segments 
with a score of 3 as definitely abnormal. Reversibility of segmental scores 
influenced the interpretation t ward abnormal. Assignment ofsegmental 
scores took into account knowledge ofnormal segment variation. Seg- 
mental scores of 1 were assigned tosegments with equivocal reduction i
radioactivity or when defects were considered secondary to attenuation r 
when apparent apical defects were considered likely to represent ormal 
apical thinning. Similarly, defects considered secondary to breast attenu- 
ation were assigned scores of 1. 
cant exertional hypotension. Whenever possible, beta- 
adrenergic blocking agents and calcium channel antagonists 
were discontinued 48 h before testing and nitrates 6 h before 
testing. The maximal degree of ST segment change at 80 ms 
after the J point on the ECG was measured and assessed as 
horizontal, upsloping or downsloping. Exercise ECG responses 
were considered uninterpretable if the patients were taking 
digoxin or had a paced ventricular rhythm or if the ECG 
demonstrated left ventricular hypertrophy, nonspecific ST-T 
wave changes, left or right bundle branch block or Wolff- 
Parkinson-White syndrome. At near-maximal exercise, a 20- to 
30-mCi dose of Tc-99m sestamibi was injected, with dose 
variation based on patient weight. Technetium-99m sestamibi 
SPECT was begun 15 to 30 min after radioisotope injection. 
All SPECT studies utilized a scintillation camera/computer 
system equipped with a high resolution collimator. The SPECT 
imaging studies were performed as previously described (21), 
using a circular 180 o acquisition for 64 projections at 20 s/ 
projection for Tc-99m sestamibi and 25 s/projection for 
thallium-201. For thallium-201 imaging, two energy windows 
were utilized, including a 30% window centered on the 68- to 
80-keV peak and a 10% window centered on the 167-keV 
peak. For Tc-99m sestamibi SPECT, a 15% window centered 
on the 140-keV peak was used. Images were acquired using a 
64 x 64 image matrix. All images were subject to quality 
control measures as previously described (21). No attenuation 
or scatter correction was used. 
Image interpretation. Visual interpretation was performed 
using short-axis, vertical and horizontal long-axis tomograms 
that were displayed on transparency film at 2-pixel thickness 
with staggered summation (23). The intensity of each image 
was normalized to the highest pixel value in that image. The 
short-axis and vertical ong-axis myocardial tomograms were 
divided into 20 segments for each study (Fig. 1). These 
segments were assigned to six evenly spaced regions in the 
apical, midventricular nd basal slices of the short-axis views 
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and two apical segments on the midventricular long-axis lice. 
Segments were scored at rest and stress by consensus of two 
experienced observers using a five-point scoring system (0 = 
normal; 1 = equivocal; 2 -- moderate; 3 = severe reduction of 
radioisotope uptake; 4 = absence of detectable tracer uptake 
in a segment). At the time of initial interpretation, the 
observers were unaware of clinical history and results of 
exercise testing. On the basis of the number and severity of 
segments with scores ->2, the observers judged the study results 
as normal, probably normal, equivocal, probably abnormal or 
definitely abnormal (23) (Fig. 1). The observers were then made 
aware of the patient's clinical history and the results of exercise 
testing and formed a final interpretation f the study, which by 
agreement among observers could not vary by more than one 
grade from the initial (blinded) interpretation. 
Scintigraphic ndexes. To further define the study results 
as normal or abnormal on a segment by segment basis, a 
summed stress score was defined. Before calculation of the 
summed stress score, segments with scores of 1 on stress 
images and ->1 on rest images were converted to 0 because, in 
our experience, this scoring pattern with dual-isotope SPECT 
is most commonly a normal variant. The summed stress core 
was then obtained by adding the stress scores of the 20 
segments analyzed (Fig. 1). The summed stress core had to be 
<4, and the final scan interpretation had to be definitely 
normal, probably normal or equivocal for the study to be 
considered in the normal or equivocal subgroups. 
Patient follow-up. For purposes of the present study, we 
define cardiac death (confirmed by review of death certificate 
or hospital chart) and nonfatal myocardial infarction (docu- 
mented by appropriate ECG and cardiac enzyme level 
changes) as hard events and bypass urgery or coronary angio- 
plasty >60 days after testing as soft events. We previously (6,7) 
observed that patients who undergo revascularization within 
the first 60 days after nuclear testing tend to do so, in part, on 
the basis of their scan results, whereas patients referred to 
revascularization >60 days after nuclear testing tend to be 
referred because of worsening of their clinical status. However, 
in the present study this censoring was only applied to patients in 
the group with abnormal scan results. All patients included in this 
report were followed up for at least 1 year (mean [+SD] 
follow-up interval 20 ___ 5 months). Unless otherwise noted, the 
event rates described are those over the entire follow-up eriod. 
Likelihood of coronary artery disease. For the purpose of 
analyzing patients in different risk subsets, we used analysis of 
the pre-ETr and post-ETT (prescan) likelihood of anglo- 
graphically significant coronary artery disease on the basis of 
sequential Bayesian analysis of age, gender, symptom classifi- 
cation, risk factors and the results of ECG stress testing as 
aggregate clinical descriptors of proven prognostic importance 
(27). In patients with uninterpretable exercise ECG responses, 
the pre-ETT and post-ETr likelihoods of coronary artery 
disease were considered equal. 
Statistical analysis. Comparisons between patient groups 
were performed using a one-way analysis of variance for 
continuous variables and a chi-square test for categoric vari- 
ables. All continuous variables are reported as mean value __ 
SD; p < 0.05 was considered significant. 
Cumulative survival rates as a function of time after the 
index nuclear exercise test were calculated using the Kaplan- 
Meier method and compared using the Mantel-Cox test 
(28,29). Incremental prognostic value of the scan was defined 
as a statistically significant difference in event-free survival 
rates between patients with normal versus abnormal scan 
results. This analysis was performed separately in patients with 
interpretable and uninterpretable exercise ECG responses. In 
patients with interpretable exercise ECG responses, those with 
a low pre-ET-f likelihood of coronary artery disease (<0.15) 
were eliminated from analysis because these patients are at low 
risk regardless of the outcome of testing. The remaining 
patients were classified by post-ETI" likelihood of coronary 
artery disease into low (<0.15) and intermediate to high 
(->0.15) likelihood groups. These two clinical risk groups were 
further stratified by the nuclear scan results. Incremental 
prognostic value was defined as improved stratification, that is, 
a statistically significant difference in the survival rates of 
patients with normal versus abnormal scan results (p < 0.05 by 
Mantel-Cox testing). Similarly, patients with uninterpretable 
exercise ECG responses, who are not generally considered for 
exercise testing before nuclear testing, were stratified first by 
pre-ETT likelihood of coronary artery disease into low and 
intermediate o high clinical risk groups and then by their 
nuclear scan result into subgroups. Incremental value was 
determined in the uninterpretable exercise ECG response 
group as described earlier. In all cases, normal scans included 
results interpreted as normal, probably normal or equivocal. 
Abnormal scans included results interpreted as probably abnor- 
mal or definitely abnormal. The incremental value was quantified 
by the chi-square statistic generated by the Mantel-Cox test. 
Cost analysis. To evaluate the expense associated with 
clinical strategies utilizing nuclear testing we assumed costs of 
exercise ECG testing, nuclear testing and cardiac atheteriza- 
tion based on Medicare reimbursement i  our institution (ETT 
$175, nuclear test $840, and cardiac catheterization with 
angiography $2,800). For a clinical strategy to be acceptable, 
the hard event rate in patients not referred to catheterization 
could not exceed l%/year of follow-up. 
We compared the costs of four different clinical strategies 
in the patients with interpretable ECG responses: 1) cardiac 
catheterization in all patients with a pre-ETT likelihood of 
coronary artery disease >0.15; 2) exercise ECG in all patients 
with a pre-ETT likelihood >0.15 and subsequent catheteriza- 
tion in patients with a post-ETT likelihood >0.15; 3) exercise 
ECG in patients with a pre-ETT likelihood >0.15, nuclear scan 
in patients with a post-ETr likelihood >0.15 and catheteriza- 
tion in patients with an abnormal scan; and 4) nuclear scan in 
all patients with a pre-ETT likelihood >0.15 and catheteriza- 
tion in all patients with an abnormal scan. 
In the patient cohort with uninterpretable ECG responses, 
four clinical strategies were compared as well: 1) cardiac 
catheterization in all patients; 2) cardiac catheterization in all 
patients with a pre-ETl7 likelihood of coronary artery disease 
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Table 1. Patient Demographics 
Normal* Abnormal 
Scan Results Scan Results p 
(n = 1,131) (n = 571) Value 
Age (yr) 60 _+ 13 65 -+ 12 0.001 
Gender (male) 610 (54%) 427 (75%) 0.001 
DM 101 (9%) 77 (13%) 0.005 
HX M1 42 (4%) 140 (24%) 0.001 
Pre-EYI" LK CAD 0.27 _+ 0.26 0.42 _+ 0.26 0.001 
Post-ETY LK CAD 0.27 +_ 0.3(I 0.48 _+ 0.36 0.001 
Symptoms 
Asymptomatic 423 (37%) 217 (38%) NS 
Nonanginal 354 (31%) 96 (17%) 0.001 
Atypical angina 242 (22%) 137 (24%) NS 
Typical angina 83 (7%) 104 (18%) 0.001 
Dyspnea 29 (3%) 17 (3%) NS 
Exercise time (rain) 7.6 _+__ 3.0 6.6 - 2.8 0.001 
Maximal predicted HR achieved (%) 95 + 9 90 -+ 10 0.001 
<85% maximal HR achieved 106 (9%) 131 (23%) 0.001 
ECG response 
Nonischemic 550 (49%) 185 (32%) 0.001 
Nondiagnostic 163 (14%) 130 (23%) 0.00l 
Equivocal 123 (11%) 44 (8%) NS 
Ischemic 295 (26%) 211 (37%) 0.001 
Clinical response 
Nonischemic 985 (87%) 407 (71%) 0.001 
Ischemic 67 (6%) 106 (19%) 0.001 
Equivocal 58 (5%) 24 (4%) NS 
Abnormal 21 (2%) 34 (6%) 0.001 
* Includes normal, probably normal and equivocal scan results. Data presented are mean value _+ SD or number (%) 
of patients. DM = diabetes mellitus; ECG = electrocardiographic; ETr = exercise treadmill test; HR = heart rate; 
HX MI - history, of myocardial infarction; LK CAD = likelihood of coronary artery disease. 
>0.15; 3) nuclear scan in all patients and subsequent catheter- 
ization in patients with an abnormal scan; and 4) nuclear scan 
in all patients with a pre-ETT likelihood >0.15 and catheter- 
ization in patients with an abnormal scan. 
A number of assumptions were made in our analysis. The 
frequency of hard events and the distribution frequencies of 
pre-ETT and post-ETT likelihoods of coronary artery disease 
and scan results were assumed from the patient cohort in this 
study. The end point of the cost analysis was referral to 
catheterization after screening. In clinical strategies not utiliz- 
ing a nuclear scan, the cost of a nuclear scan that might be 
required after catheterization to evaluate appropriateness for
revascularization was not included in the overall cost of the 
strategy. We also assumed that all high risk patients would be 
correctly identified by cardiac atheterization. 
Resu l ts  
Patient characteristics. The clinical characteristics of the 
study patients are illustrated in Table 1. The normal/equivocal 
scan group was fairly balanced between men and women (54% 
men) and was younger and included a greater proportion of 
women, a lower proportion of patients with either previous 
myocardial infarction or known diabetes and patients with a 
lower pre-ETT likelihood of coronary artery disease than the 
abnormal scan group. 
Observed events. In the 1,702 study patients, there were 45 
hard events (18 cardiac deaths, 27 myocardial infarctions 
[2.6%]) and 50 soft events (29 angioplasty and 21 bypass 
surgery procedures [5,6%]). In the 1,131 patients with a normal 
or equivocal scan, there were two hard events (one cardiac 
death, one myocardial infarction [0.2%]) and eight soft events 
(four angioplasty and four bypass urgery procedures [0.9%]). 
Both hard events occurred in patients with a normal scan. In 
the 571 patients with an abnormal scan there were 43 hard 
events (7.5%) and 85 total events (14.9%). The frequencies of
hard and soft events were significantly greater in patients with 
an abnormal scan than in those with a normal or equivocal scan 
(p < 0.001 for both). 
Frequency of events as a function of post-ETT likelihood of 
coronary artery disease in patients with a normal and equiv- 
ocal scan. Figure 2 depicts the frequency of events in patients 
with a low (<0.15), intermediate (0.15 to 0.85) and high 
(>0.85) post-ETT likelihood of coronary artery disease. Of the 
90 patients with a high post-ETr likelihood of coronary artery 
disease, none had a hard cardiac event, and 2 had soft events 
(2.2%). Of the 60t patients with a low post-ETT likelihood of 
coronary artery disease, none had a hard event, and 2 had a 
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Figure 2. Frequencies of hard (myocardial nfarction or cardiac death) 
and soft (late coronary angioplasty or bypass urgery) events over the 
follow-up eriod in patients with a low, intermediate or high post- 
exercise treadmill test likelihood of coronary artery disease (POST- 
ETF LK CAD). Solid bars = abnormal scan results; hatched bars = 
normal scan results. *p < 0.05. 
soft event. Of the 440 patients with an intermediate post-ETT 
likelihood of coronary artery disease, 2 had a hard event 
(0.4%), and 4 had a soft event. 
Frequency of events as a function of scan type. The 
relation between the final scan interpretation category and 
total events is illustrated in Figure 3. A very low frequency for 
hard events was noted in patients with a normal, probably normal 
or equivocal scan. No hard events occurred in the 87 patients with 
an equivocal scan; however, soft events occurred in 3 of these 
patients (3.4%), significantly more frequent than in patients with 
a normal or probably normal scan (5 of 1,044, p = 0.01). 
Frequency of subsequent cardiac catheterization in pa- 
tients with a normal or equivocal scan. Of the 601 patients 
with a low post-ETT likelihood of coronary artery disease, 4 
(0.7%) were referred for cardiac atheterization in the first 60 
days after the nuclear scan. In the intermediate and high 
Figure 3. Scan results versus event rate. Rates of hard (hatched bars) 
and soft events (dotted bars) over the follow-up eriod in patients with 
normal, probably normal and equivocal scan results. *p < 0.05. 
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post-ETT likelihood patient groups, 9 (2%) of 440 and 3 
(3.3%) of 90 patients, respectively, were referred for cardiac 
catheterization. Although there was a significant difference in 
the referral rate between groups (p < 0.05), the rate of 
catheterization was low in all groups. 
Incremental prognostic value. Interpretable xercise ECG 
responses. To determine the incremental prognostic value of 
the nuclear scan, we examined whether the scan result im- 
proved the stratification of patients over that achieved by 
exercise ECG testing alone (Fig. 4). Of the 1,282 patients with 
interpretable exercise ECG responses (and a normal or abnor- 
mal scan), 548 had a low pre-ETT likelihood of coronary artery 
disease, 3 (0.5%) of whom had a hard event. Of these 548 
patients, none of 441 with a normal or equivocal scan and 3 
(2.8%) of 107 with an abnormal scan had a hard event. In the 
remaining 734 patients with an intermediate ohigh pre-ETT 
likelihood of coronary artery disease, a low post-ETr likeli- 
hood of coronary artery disease identified a group of patients 
with a low hard event rate (1.7% [4 of 231]), and an interme- 
diate to high post-ETr likelihood of coronary artery disease 
identified agroup of patients with an intermediate hard event 
rate (4.0% [20 of 503]). In patients with a low post-ETT 
likelihood of coronary artery disease, those with a normal scan 
had a significantly lower hard event rate (0% [0 of 167]) than 
those with an abnormal scan (6.2% [4 of 64], chi-square 7, p = 
0.007). However, even greater stratification occurred in the 
patients with an intermediate o high post-ETF likelihood of 
coronary artery disease (normal scan, 0.7% [2 of 274]; abnor- 
mal scan, 7.9% [18 of 229], chi-square 18, p < 0.001]. 
Uninterpretable exercise ECG responses. To determine the 
incremental value of a normal or equivocal nuclear scan in 
patients with uninterpretable exercise ECG responses, we 
examined the ability of the scan to enhance the stratification of 
patients with coronary artery disease over that achieved by the 
pre-ETT likelihood of coronary artery disease alone (Fig. 5). 
Of the 420 patients with uninterpretable exercise ECG re- 
sponses, 18 (4.3%) had a hard event (2 of 118 [1.7%] with a low 
pre-ETr likelihood of coronary artery disease and 16 of 302 
[5.3%] with an intermediate o high pre-ETr likelihood of 
coronary artery disease). Of the 118 patients with a low 
pre-ETT likelihood of coronary artery disease, 83 with a 
normal or equivocal scan had no hard or soft events during 
follow-up, and 35 with an abnormal scan had two hard events 
(5.7%) and two soft events (5.7%). An abnormal scan and a 
low pre-ETT likelihood of coronary artery disease significantly 
stratified patients with respect to total events (chi-square 7, p 
= 0.01). Of the 302 patients with an intermediate o high 
pre-ETT likelihood of CAD, 151 with a normal or equivocal 
scan had no hard events during follow-up, and 151 with an 
abnormal scan had 16 hard events (10.6%) during follow-up. A 
normal or equivocal scan significantly stratified patients in this 
group (chi-square 15, p < 0.001). Thus, these results demon- 
strate the incremental prognostic value of nuclear exercise 
testing in all patient groups. 
Results of cost analysis, We estimated the cost of nuclear 
exercise testing in patients with interpretable and uninterpret- 
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Figure 4. Outcomes in patients with inter- 
pretable xercise lectrocardiographic 
(ECG) responses. EVENTS = hard 
events (frequency); INT-HIGH = inter- 
mediate to high; PRE-ETT (POST- 
ETT) LK CAD = pre (post)-exercise 
treadmill test likelihood of coronary 
artery disease; PTS = patients. 
able exercise ECG responses to determine whether the incre- 
mental prognostic value resulted in greater costs than other 
testing strategies. 
In patients with interpretable xercise ECG responses 
(Table 2), the clinical strategy sequentially utilizing exercise 
electrocardiography, nuclear scan and catheterization (strategy 
3 [see Methods]) in patients with a >0.15 post-ETI" likelihood 
of coronary artery disease was least expensive ($1,729/patient). 
Extending the use of nuclear exercise testing to patients with a 
low post-ETr likelihood of coronary artery disease increased 
the overall cost by $389/patient. Strategy 3 was 17% less 
expensive than the least expensive nonnuclear strategy. 
In patients with uninterpretable exercise ECG responses 
(Table 3), the strategy utilizing nuclear exercise testing in 
patients with a pre-ETr likelihood of coronary artery disease 
>0.15 and cardiac atheterization in patients with an abnormal 
scan was the least expensive ($1,726/patient). This strategy was 
14% less expensive than the interventional strategy in the 
present study population. 
Discussion 
Prognostic implications of a normal or equivocal myocar- 
dial perfusion scan. The results of the present study in a 
population who underwent exercise Tc-99m sestamibi myocar- 
dial perfusion SPECT demonstrate hat normal or equivocal 
scan results are associated with a benign prognosis. A very low 
rate of hard events was observed in these patients regardless of 
the post-ETT likelihood of coronary artery disease. The refer- 
ral rate for catheterization in these patients was low in all 
patients with a post-ETr likelihood of coronary artery disease, 
suggesting an appropriate impact on patient management. The 
population on which the present study is based is representa- 
tive in terms of age, gender and symptoms of the population 
referred for testing at a large community hospital and, thus, 
our results may be generalizable to this setting. 
The results of the present study compare favorably with 
those of previous thallium-201 and Tc-99m sestamibi studies 
that have associated a benign prognosis with normal exercise 
UNINTERPRETABLE EXERCISE ECG RESPONSES 
420 PTS: 18 EVENTS (43%) 
Y 
LOW PRE-ETT LK CAD 
(<0.15i 
118 PTS; 2 EVENTS (17%) 
/ ",,, 
NORMAL SCAN ABNORMAL SCAN 
83 PTS; 35 PrS: 
NO EVENTS (0%) 2 EVENTS (5 7%) 
INT-mGH PRE-ETT LK CAD 
(_>0 15) 
302 PTS: 6 EVENTS (5.3%) 
/ -.... 
NORMAL SCAN ABNORMAL SCAN 
151 PTS: 151 PTS; 
NO EVENrS (0%) 16 EVENTS (106%) 
Figure 5. Outcomes inpatients with uninterpret- 
able exercise lectrocardiographic (ECG) re- 
sponses. Abbreviations a in Figure 4. 
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Table 2. Costs Of Four Clinical Strategies Tested in 734 Patients With Interpretable Exercise 
Electrocardiographic Responses 
Nuclear Total Cost per 
Exercise Cardiac Cost Patient 
Strategy ETF Test Catb ($) ($) 
1 0 0 734 2,055,200 2,800 
(0%) ((1%) (100%) 
2 734 0 51)3 1,533,100 2,089 
(100%) (0%) (68%) 
3 734 503 229 1,268,980 1,729 
4 0 734 293 1,554,400 2,118 
(0%) (100%) (40%) 
Data presented are number (%) of patients, unless otherwise indicated. Strategy 1 = cardiac atheterization (Cath) 
in all patients with pre-exercise treadmill test (Err)  likelihood of coronary artery disease >0.15; strategy 2 exercise 
electrocardiogram (ECG) in all patients with pre-ETT likelihood of coronary artery disease >0.15, catheterization i  
patients with post-ETI' likelihood of coronary artery disease >0.15; strategy 3 = exercise ECG in patients with pre-ETT 
likelihood of coronary artery disease >0.15, nuclear exercise testing in patients with post-Err likelihood of coronary 
artery disease >0.15, catheterization i  patients with abnormal nuclear scan results; strategy 4 nuclear exercise testing 
in all patients with pre-ETT likelihood of coronary artery disease >0.15, catheterization i  patients with abnormal scan 
results. 
myocardial perfusion scan results. Brown (15) summarized the 
results of 16 thallium-201 studies in 1991, reporting a 0.9% 
hard event rate/year in 3,594 patients followed-up for a mean 
of 29 months. Machecourt et al. (30) reported a cardiovascular 
mortality rate of 0.1%/year in 715 patients with normal 
thallium-201 SPECT results. Using exercise Tc-99m sestamibi 
SPECT, Stratmann et al. (16) reported a similar hard event 
rate of 0.5%/year in 209 patients with chest pain syndromes 
followed up for 13 _+ 5 months after normal study results. 
Brown et al. (17), using planar exercise Tc-99m sestamibi, 
reported a hard event rate of 0.5%/year for 234 patients 
followed up for 10 _+ 2 months. Importantly, the combined 
data set now includes a very large patient population in which 
there has been a consistently benign prognosis associated with 
normal exercise Tc-99m sestamibi or thallium-201 study results. 
Results in patients with a high likelihood of coronary artery 
disease. Of particular importance for patient management 
decisions are the results in the subset of patients with a high 
post-ETT likelihood of coronary artery disease. Such patients 
are often sent directly to the catheterization laboratory, and 
decisions regarding revascularization are frequently made on 
the basis of anatomic findings observed on angiography. When 
patients have intractable symptoms, this direct referral to 
catheterization appears to be appropriate. However, the 
present study showed an extremely ow hard cardiac event rate 
in patients with a high post-ETF likelihood of coronary artery 
disease and normal or equivocal scan results (no hard events in 
87 patients) and provides the basis for an alternative strategy in 
this cohort; thus, patients with typical angina whose symptoms 
respond to therapy may avoid unnecessary invasive manage- 
ment if the results of nuclear scintigraphy indicate a benign 
prognosis. In fact, we also found a uniformly low rate of 
referral for catheterization f rall study patients with normal or 
equivocal scan results and a post-ETT likelihood of coronary 
artery disease. Given the low hard event rate in these patients, 
this finding suggests that the scan result had an impact on 
Table 3. Costs of Four Clinical Strategies Tested in Patients With Uninterpretable Exercise 
Electrocardiographic Responses 
Nuclear Cardiac Total Cost Cost per 
Strategy ETT Exercise Test Cath ($) Patient ($) 
1 1) 0 420 1,176,000 2,800 
(0%) (0%) (100%) 
2 0 0 302 845,600 2,013 
(0%) (0%) (72%) 
3 0 420 186 940,800 2,240 
(0%) (100%) (46%) 
4 0 302 151 724,800 1,726 
(0%) (72%) (38%) 
Data presented are number (%) of patients, unless otherwise indicated. Strategy 1 - cardiac atheterization (Cath) 
in all patients; strategy 2 = cardiac catheterization i  all patients with pre-exercise treadmill test (ETT) likelihood of 
coronary, artery disease >0.15; strategy 3 = nuclear exercise testing in all patients, subsequent cardiac catheterization; 
strategy 4 - nuclear exercise testing in all patients with pre-ETI' likelihood of coronary artery disease >0.15, subsequent 
cardiac atheterization i  patients with abnormal scan results. 
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patient management by appropriately influencing physician 
use of invasive testing. 
Incremental prognostic value and cost analysis. When the 
complete spectrum of scan responses was considered, perfu- 
sion scans were found to yield incremental prognostic value 
and to enhance prognostic stratification. In patients with 
interpretable exercise ECG responses, incremental prognostic 
information was present in the subgroups with both interme- 
diate to high and low post-ETY likelihoods of coronary artery 
disease. The use of nuclear exercise testing in the former group 
was found to contribute to an economically superior clinical 
strategy; the prognostic use of nuclear exercise testing in the 
low post-ET-I" likelihood of coronary artery disease group 
could not be justified on the basis of cost. In patients with 
uninterpretable exercise ECG responses, perfusion scans had 
incremental prognostic value in the subgroups with both 
intermediate to high and low pre-ETI" likelihoods of coronary 
artery disease and, in the former, was part of an economically 
superior strategy. 
Previous tudies utilizing thallium imaging in patients with 
interpretable ECG responses to predict he presence of mul- 
tivessel disease reported that the cost of thallium testing did 
not justify the associated added expense (31). The current 
study examined clinical testing strategies incorporating multi- 
ple modalities--clinical variables, ETF and nuclear exercise 
testing. The cost savings of the strategy combining all modal- 
ities emphasizes the importance of identifying the appropriate 
population i which each of the individual modalities should be 
used. This important finding would be missed by using a 
multivariate analysis, which "lumps" together all patient 
groups (the approach used by previous investigators). A strat- 
ification approach, such as survival analysis or patient sub- 
grouping by likelihood of coronary artery disease or rest ECG, 
allows examination of important clinical subgroups. This ap- 
proach was possible in our study because of the greater size of 
our cohort. Furthermore, differences between our and the 
previous tudy (31) may also have been due to differences in 
the end points studied (multivessel disease vs. hard events) or 
referral bias (the previous tudy was limited to a population 
that also had undergone catheterization). 
Assumptions of cost analysis. In our cost analysis, we 
limited our outcome to referral to a diagnostic procedure 
(angiography) and did not take into account he costs of 
possible subsequent revascularizations. We also assumed, for 
the purpose of this analysis, that all patients referred irectly to 
angiography would not need nuclear exercise testing. This 
assumption introduces an underestimation f costs in the 
nonnuclear strategies, because anumber of patients (-15% in 
our institution) would be referred for nuclear exercise testing 
before revascularization to assess the physiologic significance 
of any lesion found by angiography. This analysis also assumes 
that he assessment of coronary angiographic data would result 
in an effective stratification of patients with a pre-ETI" likeli- 
hood of coronary artery disease >0.15 into high and low risk 
subsets. Although reasonable, this assumption could not be 
tested in our study population, because all such patients did 
not undergo catheterization. Furthermore, although a fraction 
of the patients with normal scan results would be found to have 
coronary artery disease if referred to angiography, their prog- 
nosis, as recently shown, would still be benign (32,33). 
Study limitations. In the present report, scintigraphic stud- 
ies were assessed by highly experienced observers using visual 
interpretation. We have developed a standardized, semiquan- 
titative approach to visual interpretation (23) and have docu- 
mented its excellent reproducibility (21). Nonetheless, the 
subjective nature of this analysis and its dependence on the 
expertise of the observer presents a limitation with respect o 
the extrapolation of our results to those of other centers. Less 
subjective quantitative methods for analysis of Tc-99m myo- 
cardial perfusion SPECT studies have been developed (34), 
that correlate highly with both visual scan assessment and 
coronary angiography (35). At the time of collection of the 
SPECT study results in the present patient population, we did 
not have a quantitative analysis technique inoperation on all of 
our camera/computer systems. Prognostic studies using quan- 
titative analysis would be of interest. A further limitation of the 
present study is that the results are based on a population 
referred for nuclear exercise testing and therefore may not be 
applicable to a broader population. 
The SPECT studies used a specific imaging protocol of 
exercise Tc-99m sestamibi and rest thallium-201 acquisitions. 
However, the nuclear variables analyzed in the present study 
(summed stress score and overall scan interpretation) were 
virtually completely determined by the exercise Tc-99m sesta- 
mibi portion of the study. Thus, we consider it likely that the 
results would have been the same for a 2-day protocol using 
exercise and rest Tc-99m sestamibi SPECT. In addition, Tc- 
99m sestamibi imaging was begun 15 to 30 min after exercise, 
as opposed to the originally described 1- to 2-h interval 
(9,18-20). Taitlefer et al. (36) recently showed that there is no 
significant change in Tc-99m sestamibi defects images obtained 
15 rain and 1 h after exercise injection are compared. Whether 
the benign prognostic implications of normal or equivocal scan 
results will also apply to Tc-99m sestamibi SPECT studies 
acquired late after stress injection cannot be inferred from the 
present data. 
Clinical implications. On the basis of this and other studies 
reported to date it is now clear that normal or equivocal 
exercise Tc-99m sestamibi study results, using a protocol in 
which imaging is begun within 1 h after injection, are associ- 
ated with a benign prognosis. Because this benign prognosis 
extends to patients with a high post-ETT likelihood of coro- 
nary artery disease, the results suggest hat a noninvasive 
strategy for the assessment ofpatients with a high likelihood of 
coronary artery disease may be safe and effective, thus avoiding 
unnecessary invasive procedures. 
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